These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 22158075

  • 1. Biological and prognostic relevance of mitogen-activated protein kinases in pancreatic adenocarcinoma.
    Handra-Luca A, Lesty C, Hammel P, Sauvanet A, Rebours V, Martin A, Fagard R, Fléjou JF, Faivre S, Bédossa P, Ruszniewski P, Couvelard A.
    Pancreas; 2012 Apr; 41(3):416-21. PubMed ID: 22158075
    [Abstract] [Full Text] [Related]

  • 2. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
    Liu XD, Zhang ZW, Wu HW, Liang ZY.
    Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma.
    Lu J, Zhou L, Yang G, Liang ZY, Zhou WX, You L, Yuan D, Li BQ, Guo JC, Zhao YP.
    Hum Pathol; 2019 Apr; 86():143-154. PubMed ID: 30537492
    [Abstract] [Full Text] [Related]

  • 4. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
    Shin SH, Kim SC, Hong SM, Kim YH, Song KB, Park KM, Lee YJ.
    Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
    Huang C, Huang K, Wang C, Jiang ZD, Li XX, Wang HP, Chen HY.
    Oncol Rep; 2009 Jul; 22(1):89-95. PubMed ID: 19513509
    [Abstract] [Full Text] [Related]

  • 6. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC, Hoen HM, Cassera MA, Newell PH, Hammill CW, Hansen PD, Wolf RF.
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
    Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L, Nahta R, Buchholz TA, Buzdar AU, Hortobagyi GN, Bacus SS.
    Cancer; 2004 Feb 01; 100(3):499-506. PubMed ID: 14745865
    [Abstract] [Full Text] [Related]

  • 8. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H.
    Clin Cancer Res; 2008 Nov 01; 14(21):7043-9. PubMed ID: 18981001
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
    Golse N, Lebeau R, Lombard-Bohas C, Hervieu V, Ponchon T, Adham M.
    Pancreas; 2013 Mar 01; 42(2):239-48. PubMed ID: 23038054
    [Abstract] [Full Text] [Related]

  • 12. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
    Lytras D, Leontara V, Kefala M, Foukas PG, Giannakou N, Pouliakis A, Dervenis C, Panayiotides IG, Karakitsos P.
    Pancreas; 2015 Jan 01; 44(1):87-92. PubMed ID: 25058886
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.
    Yu XZ, Guo ZY, Di Y, Yang F, Ouyang Q, Fu DL, Jin C.
    Hepatobiliary Pancreat Dis Int; 2017 Feb 01; 16(1):104-109. PubMed ID: 28119265
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.
    Handra-Luca A, Hammel P, Sauvanet A, Ruszniewski P, Couvelard A.
    J Hepatobiliary Pancreat Sci; 2013 Mar 01; 20(3):294-302. PubMed ID: 22581056
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A and B blood group antigens in human pancreatic ductal adenocarcinomas.
    Handra-Luca A.
    Oncology; 2013 Mar 01; 84(3):141-9. PubMed ID: 23257765
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.